Second or subsequent remission with a disease-free survival of 5 years or longer in acute lymphocytic leukemia of childhood: results of a national survey
Musgrave, S.; Dickerman, J.D.; Land, V.J.
Pediatrics 77(5): 765-769
1986
ISSN/ISBN: 0031-4005 PMID: 3458157 Document Number: 278000
A national survey was conducted to determine the number of children with acute lymphocytic leukemia who have survived 5 years or longer in their second or subsequent remission. Seventy-two such patients were identified. The clinical and laboratory characteristics of these patients as well as their therapy are described. It is concluded that long-term second or subsequent remission may occur more frequently than previously appreciated.
Document emailed within 1 workday
Related Documents
Anderlini, P.; Ghaddar, H.M.; Smith, T.L.; Pierce, S.; Kantarjian, H.M.; O'Brien, S.; Keating, M.J.; Freireich, E.J.; Estey, E.H. 1996: Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first Leukemia 10(6): 964-969Pratt, C.B.; Roberts, D.; Shanks, E.; Warmath, E.L.; Jackson, R. 1973: Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia Cancer Research 33(9): 2020-2025
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
Verzosa, M.; Fite, A. 1971: Efficacy and morbidity of daunomycin (NSC-82151) added to vincristine (NSC-67574) and prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia Cancer ChemoTherapy Reports 55(1): 79-82
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Kisliak, N.S.; Chernov, V.M.; Kondratchik, K.L.; Pronina, L.K.; Stolov, A.M. 1994: Duration of the first remission and survival rate of children with acute lymphoblastic leukemia after use of thymus preparations in the remission period Gematologiia i Transfuziologiia 39(5): 43-44
Zegarac, M.; Nikolic, S.; Gavrilovic, D.; Jevric, M.; Kolarevic, D.; Nikolic-Tomasevic, Z.; Kocic, M.; Djurisic, I.; Inic, Z.; Ilic, V.; Santrac, N. 2013: Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 18(4): 859-865
Yoshikawa, H.; Sao, H.; Tahara, T.; Akao, Y.; Yoshikawa, S. 1984: A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 515-520
Balcárková-Sebánková, H.; Reddemann, H. 1980: Characteristics of children with a longer survival time in acute lymphoblastic leukemia Ceskoslovenska Pediatrie 35(11): 602-605
Cantore, N.; Fotino, A.; Volpe, S.; Santaniello, L.; Pagnini, D.; Volpe, E. 1985: A case of transformation of an untreated acute lymphocytic leukemia into acute erythroblastic leukemia (di Guglielmo's disease) Haematologica 70(4): 375-376
Michel, K.; Hubbel, C.; Dock, N.L.; Davey, F.R. 1981: Correlation of HLA-DRw3 with childhood acute lymphocytic leukemia Archives of Pathology and Laboratory Medicine 105(10): 560
Bowman, W.P. 1981: Childhood acute lymphocytic leukemia: progress and problems in treatment Canadian Medical Association Journal 124(2): 129-142
Smith, F.O.; Raskind, W.H.; Waldron, P.; Steinmann, L.J.; Matsushita, M.; Singer, J.W.; Lampkin, B.C.; Woods, W.G.; Lange, B.J.; Hammond, G.D. 1993: Clonal remission in childhood acute myeloid leukemia is an infrequent event Leukemia 7(7): 929-932
Aur, R.J.; Simone, J.V.; Verzosa, M.S.; Hustu, H.O.; Barker, L.F.; Pinkel, D.P. 1975: Comparison of four schedules of chemotherapy during remission of acute lymphoblastic leukemia in childhood Sangre 20(3): 237-244
Schaison, G.; Jacquillat, C.; Lemercier, N.; Alby, N.; Weil, M.; Auclerc, M.F.; Boiron, M.; Bernard, J. 1980: Complete remission of acute leukemia for more than seven years. A report on 100 children Annales de Medecine Interne 131(2): 84-86
Ohashi, H.; Ichikawa, A.; Takagi, N.; Hotta, T.; Naoe, T.; Ohno, R.; Saito, H. 1992: Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone Leukemia 6(8): 859-862
Hafiz, M.G.; Mannan, M.A. 2008: Nutritional status at initial presentation in childhood acute lymphoblastic leukemia and its effect on induction of remission Mymensingh Medical Journal: Mmj 17(2 Suppl): S46-S51
Hunyadi, K.; Nagy, K.; Velkey, L. 1984: Secondary malignant tumor in a child with acute lymphoid leukemia after 5 years of complete remission Orvosi Hetilap 125(49): 3003-3006
Griffith, C.D.; Ellis, I.O.; Bell, J.; Burns, K.; Blamey, R.W. 1990: Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival Journal of the Royal College of Surgeons of Edinburgh 35(5): 289-292
Torres, A.; Martínez, F.; Gómez, P.; Fornés, G.; Rojas, R.; Herrera, C.; Gómez, J.L.; Manzanares, R.; García, J.M.; Andres, P. 1989: Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission Bone Marrow Transplantation 4(6): 609-612